About Hemosphere
Hemosphere is a company based in Eden Prairie (United States) founded in 1987 was acquired by CryoLife in May 2012.. Hemosphere has raised $9.3 million across 1 funding round from investors including Kaiser Permanente Ventures, Three Arch Partners and Affinity Capital Management. Hemosphere offers products and services including HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters. Hemosphere operates in a competitive market with competitors including TISSIUM, Cardival Medical, Laminate Medical, Aziyo Biologics and Vivasure Medical, among others.
- Headquarter Eden Prairie, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hemosphere, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.3 M (USD)
in 1 rounds
-
Latest Funding Round
$9.3 M (USD), Series A
Mar 31, 2010
-
Investors
Kaiser Permanente Ventures
& 7 more
-
Employee Count
Employee Count
-
Acquired by
CryoLife
(May 15, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hemosphere
Hemosphere offers a comprehensive portfolio of products and services, including HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides subcutaneous access for hemodialysis to reduce infections.
Expands HeRO Graft functionality for improved vascular access.
Facilitates access in patients with venous occlusive disease.
Offers long-term access with self-centering tips for efficiency.
Funding Insights of Hemosphere
Hemosphere has successfully raised a total of $9.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $9.3 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $9.3M
-
First Round
First Round
(31 Mar 2010)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2010 | Amount | Series A - Hemosphere | Valuation | Kaiser Permanente Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Hemosphere
Hemosphere has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Kaiser Permanente Ventures, Three Arch Partners and Affinity Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in companies in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hemosphere
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hemosphere
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hemosphere Comparisons
Competitors of Hemosphere
Hemosphere operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Cardival Medical, Laminate Medical, Aziyo Biologics and Vivasure Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| domain | founded_year | HQ Location |
A device for vascular access management is developed.
|
|
| domain | founded_year | HQ Location |
AV fistula maturation and patency are supported by VasQ device.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| domain | founded_year | HQ Location |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| domain | founded_year | HQ Location |
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Hemosphere
When was Hemosphere founded?
Hemosphere was founded in 1987 and raised its 1st funding round 23 years after it was founded.
Where is Hemosphere located?
Hemosphere is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
Is Hemosphere a funded company?
Hemosphere is a funded company, having raised a total of $9.3M across 1 funding round to date. The company's 1st funding round was a Series A of $9.3M, raised on Mar 31, 2010.
What does Hemosphere do?
Hemosphere was founded in 1987 as a medical device company focused on vascular access solutions. Operations center on the development and commercialization of the Hemodialysis Reliable Outflow (HeRO) Graft, designed for patients with failing fistulas, grafts, or catheter dependency due to venous blockages. The company, previously known as GRAFTcath, Inc., rebranded in 2008 and is based in Eden Prairie, United States, serving the hemodialysis sector.
Who are the top competitors of Hemosphere?
Hemosphere's top competitors include TISSIUM, Vivasure Medical and Cardival Medical.
What products or services does Hemosphere offer?
Hemosphere offers HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters.
Who are Hemosphere's investors?
Hemosphere has 8 investors. Key investors include Kaiser Permanente Ventures, Three Arch Partners, Affinity Capital Management, Sapient Capital Partners, and Cutlass Capital.